You've never seen anything like it · Doors open inStarts at 7:00 PM ET
Skip to content

Research peptide · GH axis research

Sermorelin

Also known as GRF(1-29)NH2 · GHRH(1-29) · sermorelin acetate

A synthetic 29-residue peptide corresponding to the N-terminal fragment of growth hormone-releasing hormone, with an amidated C-terminus.

Compound type
Research peptide
Research area
GH axis
Formula
C149H246N44O42S
Average mass
3,357.882 Da
Monoisotopic mass
3,355.8187 Da
Length
29 residues

What it is

Sermorelin is a synthetic 29-residue peptide. Its molecular formula is C149H246N44O42S, its average mass is 3357.88 g/mol and its monoisotopic mass is 3355.82. It is indexed as PubChem CID 16132413.

The sequence is a fragment, not a designed molecule. Growth hormone-releasing hormone is a 44-residue hypothalamic peptide whose first 29 residues carry the activity of the full chain. Sermorelin is that stretch, capped as a C-terminal amide. Its target is the growth hormone-releasing hormone receptor, a class B G protein-coupled receptor on pituitary somatotrophs 3.

Discovery and origin

The parent hormone was characterized in the early 1980s. A 1982 paper described a 40-residue peptide with growth hormone releasing activity isolated from pancreatic tumor tissue 1. Two years later the same group isolated the hypothalamic form, determined its primary structure and confirmed it by synthesis 2. The amidated 1-29 fragment became the standard shortened form.

Structure and chemistry

The chain is linear with no cysteine, so there is no disulfide chemistry, and it is helical in membrane-mimicking solvents while largely disordered in dilute water. The C-terminal amide matters: the free-acid form differs by about one mass and is a common process impurity.

Three residues set the stability profile. The single methionine is an oxidation site that adds 16 mass when it forms the sulfoxide. Asparagine and the adjacent serine form a deamidation-prone pair, which converts an amide to a carboxylate and shifts the mass by about one. Two tyrosines give moderate ultraviolet absorbance near 280 nm, weaker than a tryptophan-containing peptide of the same length. Synthetic material is isolated as an acetate or trifluoroacetate salt.

How it is studied in the laboratory

Receptor structural biology is the clearest line of published work. A 2020 cryo-electron microscopy study resolved the receptor in complex with its native peptide ligand and a G protein, and described how the ligand's N-terminal residues, the stretch shared with sermorelin, engage the transmembrane core 3.

Work specific to the 1-29 fragment is thin. Most laboratory literature on this receptor system uses either the full-length hormone or designed antagonists, so the fragment appears more often as a reference agonist than as the object of study.

Analytical notes

Identity is confirmed by liquid chromatography with mass spectrometry in positive ion mode. At this mass the useful signals are the multiply charged series, with expected ions near m/z 1119.61 for [M+3H]3+, 839.96 for [M+4H]4+ and 672.17 for [M+5H]5+. Charge-state deconvolution is the practical identity check.

Purity is assessed by reversed-phase HPLC. The informative impurities are deletion sequences, the C-terminal free acid from incomplete amidation, the methionine sulfoxide, and deamidated species, several of which differ from the parent by about one mass and are better resolved chromatographically than by mass.

Storage and handling in the laboratory

As supplied, the material is a lyophilized powder, stored at -20 degrees Celsius, sealed and protected from light. The lyophilized state is hygroscopic, so a vial should reach room temperature before opening. Methionine-containing peptides are the ones most affected by oxidizing conditions, so an inert headspace is worthwhile.

Open questions in the literature

No experimental structure of the 1-29 fragment bound to the receptor has been published, so its binding geometry is inferred from the full-length complex 3. Comparative potency data across species and cell backgrounds are uneven, and stability data for the methionine and deamidation sites under assay conditions are sparse.

Identity check

A mass-spectrometry result for Sermorelin should show peaks near these values. A result more than about one unit away is worth a question to the testing lab. Salt forms such as acetate or TFA do not move these peaks, though they do mean less peptide in each milligram of powder.

IonExpected m/z
[M+3H]3+1119.61
[M+4H]4+839.96
[M+5H]5+672.17

References

  1. Esch FS, Bohlen P, Ling NC, et al. Biochemical and Biophysical Research Communications. 1982;109(1):152-158. doi:10.1016/0006-291x(82)91578-9. Source
  2. Ling N, Esch F, Bohlen P, Brazeau P, Wehrenberg WB, Guillemin R. Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. Proceedings of the National Academy of Sciences. 1984;81(14):4302-4306. doi:10.1073/pnas.81.14.4302. Source
  3. Zhou F, Zhang H, Cong Z, et al. Structural basis for activation of the growth hormone-releasing hormone receptor. Nature Communications. 2020;11(1):5205. doi:10.1038/s41467-020-18945-0. Source

For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease.